Strack, Peter Richard,Booher, Robert,Sriram, Venkataraman,Phillips, Joseph H.
申请号：
AU20140309199
公开号：
AU2014309199(B2)
申请日:
2014.08.15
申请国别(地区):
澳大利亚
年份:
2018
代理人:
摘要：
The present disclosure describes combination therapies comprising an antagonist of Programmed Death 1 receptor (PD-1) and the CDK inhibitor dincaciclib, and the use of the combination therapies for the treatment of cancer, and in particular for treating cancers that express PD-L1.
